Equities research analysts at Zacks Research started coverage on shares of Accelevation (NASDAQ:ACCV – Get Free Report) in a note issued to investors on Tuesday, Zacks reports. The firm set a “hold” rating on the stock.
A number of other research firms also recently weighed in on ACCV. The Goldman Sachs Group began coverage on shares of Accelevation in a research report on Monday. They issued a “buy” rating and a $22.00 target price on the stock. William Blair set a $20.00 price target on shares of Accelevation in a report on Monday. Morgan Stanley started coverage on Accelevation in a report on Monday. They issued an “equal weight” rating and a $18.00 target price on the stock. Barclays assumed coverage on shares of Accelevation in a research note on Monday. They set an “overweight” rating and a $20.00 price target on the stock. Finally, Wall Street Zen upgraded Accelevation to a “hold” rating in a research note on Saturday, October 10th. Seven research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $19.43.
Get Our Latest Research Report on Accelevation
Accelevation Stock Up 11.7%
NASDAQ:ACCV opened at $15.03 on Tuesday. Accelevation has a 52 week low of $11.58 and a 52 week high of $18.10.
Insider Activity
In other Accelevation news, Director Howard C. Heckes bought 5,000 shares of Accelevation stock in a transaction dated Thursday, October 1st. The shares were purchased at an average cost of $18.00 per share, for a total transaction of $90,000.00. Following the acquisition, the director directly owned 5,000 shares in the company, valued at approximately $90,000. This represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Paul D. Donahue bought 7,000 shares of the firm’s stock in a transaction dated Thursday, October 1st. The shares were acquired at an average price of $18.00 per share, for a total transaction of $126,000.00. Following the completion of the transaction, the director directly owned 7,000 shares in the company, valued at approximately $126,000. This represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have bought 227,700 shares of company stock valued at $4,098,600.
More Accelevation News
Here are the key news stories impacting Accelevation this week:
- Positive Sentiment: Goldman Sachs began covering Accelevation with a “buy” rating and a $22.00 price target, implying significant upside from the referenced share price. Goldman Sachs coverage and recommendation
- Positive Sentiment: Barclays initiated coverage with an “overweight” rating and a $20.00 price target, also signaling confidence in ACCV’s future performance. Barclays coverage and recommendation
- Neutral Sentiment: Bank of America initiated coverage on Accelevation, adding another major institution to the company’s analyst following. The available report does not disclose a rating or price target. Bank of America initiates coverage on Accelevation
- Neutral Sentiment: JPMorgan Chase added Accelevation to its analyst coverage universe. No rating or target price was provided in the available information. JPMorgan Chase covers Accelevation
- Neutral Sentiment: Morgan Stanley, Wolfe Research, and Robert W. Baird also initiated coverage, increasing ACCV’s visibility among institutional investors. Their ratings and price targets were not disclosed in the supplied reports. Morgan Stanley initiates coverage Wolfe Research initiates coverage Robert W. Baird initiates coverage
About Accelevation
Accelevation Corporation NASDAQ: ACCV is a special purpose acquisition company (SPAC) formed to identify and combine with an operating business through a merger, share exchange, asset acquisition, reorganization or similar transaction.
Unlike an operating company, Accelevation does not manufacture products, provide ongoing commercial services or conduct significant business activities of its own. Its primary activities have consisted of evaluating potential acquisition targets and pursuing a business combination.
Public information about Accelevation’s operating history, geographic footprint and leadership is limited.
See Also
- Five stocks we like better than Accelevation
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Accelevation Right Now?
Before you consider Accelevation, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Accelevation wasn’t on the list.
While Accelevation currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
